Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody
Deregulated production of interleukin‐6 (IL‐6) has been found in several chronic inflammatory autoimmune disorders, including rheumatoid arthritis (RA) and inflammatory bowel diseases. Treatment with tocilizumab, a humanized anti‐human IL‐6 receptor (IL‐6R) antibody, significantly improved disease a...
Gespeichert in:
Veröffentlicht in: | BioFactors (Oxford) 2009-01, Vol.35 (1), p.47-51 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!